Oramed Pharmaceuticals (ORMP) Return on Capital Employed Growth (5y) (2016 - 2021)
Oramed Pharmaceuticals (ORMP) Return on Capital Employed Growth (5y) (2016 - 2021) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,899.87 Bn | 1,899.81 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 470.43 Bn | 465.64 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.43 Bn | 116.19 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.20 Bn | 61.44 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.75 Bn | 61.75 Bn | - |
| 8 | Argenx Se | 56.15 Bn | 50.96 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn |
| 10 | Oramed Pharmaceuticals | 167.23 Mn | 167.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2021 | 459.00 |
| Aug 31, 2019 | 252.00 |
| May 31, 2019 | -7,662.00 |
| Feb 28, 2019 | -6,769.00 |
| Nov 30, 2018 | -8,781.00 |
| Aug 31, 2018 | -10,589.00 |
| May 31, 2018 | 4,311.00 |
| Feb 28, 2018 | 2,774.00 |
| Nov 30, 2017 | 2,329.00 |
| Aug 31, 2017 | 5,741.00 |
| May 31, 2017 | 3,544.00 |
| Feb 28, 2017 | 3,581.00 |
| Nov 30, 2016 | 1,460.00 |